AMRX
Amneal Pharmaceuticals, Inc.
5.09
USD
This page is just a preview of the data found in TrendSpider’s full version
Amneal Pharmaceuticals, Inc. stock is up 25.37% since 30 days ago. The next earnings date is Feb 29, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 28 December’s closed higher than November.
Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products. The company operates through three segments: Generics, Specialty, and AvKARE. It sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies.
